search Created with Sketch.
search Created with Sketch.

Advertisement

dermwire-tv-logo Created with Sketch.
dermwire-tv-logo Created with Sketch.

BONT-A Extends Fillers; Almirall to Acquire Thermi

January 14, 2016

In this edition of DermWireTV, a look at new data showing that injections with botulinum neurotoxin can extend the efficacy of hyaluronic acid fillers. The American Academy of Dermatology Association offers more response to the USPSTF draft recommendation on the benefits of skin exams for melanoma. Almirall to exercise option to take majority share of Thermi. Allergan acquires Anterios and its topic toxin delivery platform. Anacor Pharmaceuticals, Inc. has submitted a New Drug Application to the US FDA seeking approval of crisaborole topical ointment, 2%, a novel non-steroidal topical anti-inflammatory PDE-4 inhibitor in development for the treatment of mild-to-moderate atopic dermatitis in children and adults.

Advertisement

In This Series

View More

Advertisement